Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Standardizes regional naming to 'Tatarstan, Respublika' and updates the Kazan address accordingly (v3.0.2); removes the 'Back to Top' link as a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-12T17:29:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T14:07:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The webpage has been updated with new facility names and locations, including specific cities and countries, as well as a new publication related to telisotuzumab vedotin. Additionally, the page now includes a new date for an estimated last update.
    Difference
    27%
    Check dated 2025-08-29T10:45:22.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-15T03:45:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The webpage has added numerous new locations for hospitals and medical centers across various countries, including Greater London, Cluj, and several regions in Japan and Italy. Additionally, some previously listed locations have been removed, indicating a significant update to the availability of healthcare facilities.
    Difference
    26%
    Check dated 2025-08-07T22:22:03.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-07-31T19:41:04.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.